Company Filing History:
Years Active: 2008-2011
Title: The Innovations of Hitendra S Chand
Introduction
Hitendra S Chand is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of biochemistry, particularly in the development of polypeptides with therapeutic applications. With a total of 3 patents, his work focuses on enhancing antifibrinolytic activity, which has implications for cancer treatment.
Latest Patents
One of his latest patents is titled "Human Kunitz-type inhibitor with enhanced antifibrinolytic activity." This invention describes a human Kunitz-type inhibitor polypeptide that is structurally similar to the KD1 domain of human tissue factor pathway inhibitor-2 (TFPI-2). The patent outlines methods of making and using this novel polypeptide, which can be administered to subjects afflicted with cancer or precancerous conditions. The method includes administering an effective amount of the polypeptide to induce apoptosis in tumor cells, showcasing its potential as a therapeutic agent.
Career Highlights
Throughout his career, Hitendra S Chand has worked with reputable institutions, including Stc.unm and the University of California. His research has contributed to advancements in medical science, particularly in the area of cancer treatment.
Collaborations
Hitendra has collaborated with esteemed colleagues such as Walter Kisiel and S Paul Bajaj. These collaborations have further enriched his research and innovation efforts.
Conclusion
Hitendra S Chand's work exemplifies the intersection of innovation and medical science. His contributions through patents and collaborations continue to pave the way for advancements in cancer treatment and biochemistry.